Quality of Active versus Spontaneous Reporting of Adverse Drug Reactions in Pediatric Patients: Relevance for Pharmacovigilance and Knowledge in Pediatric Medical Care.

Dittrich, Anne T M; Smeets, Nori J L; de Jong, Emma F M; Kämink, Juliët L; Kroeze, Yvet; Draaisma, Jos M Th; van Puijenbroek, Eugène P; Te Loo, D Maroeska W M

Dittrich, Anne T M; Smeets, Nori J L; de Jong, Emma F M; Kämink, Juliët L; Kroeze, Yvet; Draaisma, Jos M Th; van Puijenbroek, Eugène P; Te Loo, D Maroeska W M.

Affiliation

Dittrich ATM; Department of Pediatrics, Radboud University Medical Centre, Radboud Institute for Health Sciences, Amalia Children's Hospital, 6500 HB Nijmegen, The Netherlands.
Smeets NJL; Department of Pharmacology and Toxicology, Radboud University Medical Centre, Radboud Institute for Health Sciences, 6500 HB Nijmegen, The Netherlands.
de Jong EFM; Department of Pediatrics, Radboud University Medical Centre, Radboud Institute for Health Sciences, Amalia Children's Hospital, 6500 HB Nijmegen, The Netherlands.
Kämink JL; Department of Pediatrics, Radboud University Medical Centre, Radboud Institute for Health Sciences, Amalia Children's Hospital, 6500 HB Nijmegen, The Netherlands.
Kroeze Y; Department of Pediatrics, Radboud University Medical Centre, Radboud Institute for Health Sciences, Amalia Children's Hospital, 6500 HB Nijmegen, The Netherlands.
Draaisma JMT; Radboudumc Technology Center Clinical Studies, Radboudumc, 6500 HB Nijmegen, The Netherlands.
van Puijenbroek EP; Department of Pediatrics, Radboud University Medical Centre, Radboud Institute for Health Sciences, Amalia Children's Hospital, 6500 HB Nijmegen, The Netherlands.
Te Loo DMWM; Netherlands Pharmacovigilance Centre Lareb, 5237 MH 's-Hertogenbosch, The Netherlands.

Pharmaceuticals (Basel) ; 15(9)2022 Sep 14.

Article in En | MEDLINE | ID: mdl-36145369